Company intelligence / Profile preview

Ketamine Assisted EMDR Therapy Institute

Thousand Oaks, California, United Statesketamineassistedemdr.com ↗

Ownership: Private
Development stage: Other

Overview

The institute developed the Ketamine Assisted EMDR Therapy™ protocol in early 2024. Their pilot study demonstrated significant reductions in PTSD symptoms using a combination of low-dose ketamine and Eye Movement Desensitization and Reprocessing therapy. The approach aims to maximize memory reconsolidation for deep trauma healing. They offer on-demand courses, live virtual trainings, and consultation for clinicians. No commercial drug pipeline; focus on education/training.

Therapeutic areas: Psychiatry
Modalities: Non-pharmacological therapy (EMDR)Small molecule (ketamine)Psychedelic-assisted therapy
Industry: Academic Hospital/University/Research

Beyond the preview

Go deeper on Ketamine Assisted EMDR Therapy Institute.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ketamine Assisted EMDR Therapy Institute.

Explore the full profile